People: Synta Pharmaceuticals Corp (SNTA.O)

SNTA.O on Consolidated Issue listed on NASDAQ Global Market

7.39USD
22 May 2013
Price Change (% chg)

$-0.12 (-1.60%)
Prev Close
$7.51
Open
$7.51
Day's High
$7.79
Day's Low
$7.32
Volume
814,795
Avg. Vol
705,204
52-wk High
$11.88
52-wk Low
$3.79

Search Stocks

Rieder, Wendy 

Brief Biography

Ms. Wendy E. Rieder, Esq., is Vice President - Intellectual Property and Legal Affairs, General Counsel of Synta Pharmaceuticals Corp. She has served as General Counsel since October 2006 and as Vice President, Intellectual Property and Legal Affairs since December 2002. In August 1998, Ms. Rieder co-founded Microbiotix, Inc., a privately held biotechnology company developing small-molecule anti-infectives, and served as its Chief Operating Officer and Vice President, Business Development and Intellectual Property from January 2000 to December 2002. From August 1997 to December 1999, Ms. Rieder served as the Vice President, Business Development and Intellectual Property at LipoGenics, Inc., a subsidiary of a publicly traded biopharmaceutical company. Ms. Rieder was a patent attorney at Boehringer Ingelheim Pharmaceuticals, a U.S. affiliate of Boehringer Ingelheim GmbH, a global pharmaceutical company, from August 1995 to July 1997, and a patent agent at Fish & Neave LLP from January 1991 to July 1995. Ms. Rieder received an M.A. in organic chemistry from Columbia University and a J.D. from Fordham Law School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Keith Gollust

--

Safi Bahcall

1,610,630

Keith Ehrlich

541,550

Amar Singh

385,350

Vojo Vukovic

942,231

Wendy Rieder

--
As Of 30 Dec 2011
Search Stocks